International Journal of Research in Pharmacy and Allied Science

ISSN: 2583-6544   |  Issues per year: Monthly  |   Indexed In: Google Scholar, CORE, ScienceOpen, Researchgate

ISSN:2583-6544

Abstract View

A Brief Review on Niosomal Gel

Author(s): Bhagyashri A Patil1, Ankita P Chaudhari2, Sandip A Tadavi3, Dr. Sunil P Pawar.4

Email(s): 1bhagyashripatil3888@gmail.com

Address:

    Department of Pharmaceutics P.S.G.V.P.M’s College of Pharmacy, Shahada

Published In:   Volume - 2,      Issue - 2,     Year - 2023

DOI: Not Available

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
Infectious disease management and vaccination practices have been revolutionized in recent years. With the development of biotechnology and genetic engineering, not only have many biological agents for certain diseases been produced, but also emphasis has been placed on the effective delivery of these biological agents. An alternative to liposomes, niosomes are vesicles made of biodegradable non-ionic surfactants, which are more harmless, more stable and less expensive. This article explores the current growth and expansion of interest in niosomes in various scientific fields, with an emphasis on their application in medicine. This article also provides a general overview of preparation methods, types and characterization and applications of niosomal gel. To combat various diseases, various pharmacological substances can be administered using niosomal. It could also be used to build new drug delivery systems for poorly absorbed drugs. It increases bioavailability by overcoming anatomical barriers of the digestive system through the transcytosis of Peyer's patch M cells into intestinal lymphoid tissues.

Keywords:

Cite this article:
Bhagyashri A Patil , Ankita P Chaudhari, Sandip A Tadavi , Dr. Sunil P Pawar. A Brief Review on Niosomal Gel. IJRPAS, 2023; 2(2):70-77.


1.   Mohd.Gayoor Khan. “The novel drug delivery system”, World journal of pharmacy and pharmaceutical sciences, Vol-6, Issue 7,477-487 ISSN 2278-4357.

2.   https:/www.sciencedirect.com/science/article/pii/B9780081025482000019.

3.   Vrunal V. More, Ritu M. Gilhotra, Manoj M. Nitalikar, Prajakta K. Khule , “Niosomal drug delivery” Asian journal of pharmaceutics, Oct-Dec 2018 (suppl) 12(4)|S1159].

4.   Mohamed Shafik E1-Ridy, Soad Aly Yehia, Amira Mohamed Mohsen, Sally A E1-Awdan and AsmaaBadawyDarwish. “Formulation of niosomla gel foe enhanced transdermal Lornoxicam delivery: In-vitro and In-vivo evaluation”, Current drug delivery,2018,15,122-133

5.   Varsha B. Patil, Sandip A. Tadvi, Sunil P. Pawar."Formulation of Niosomal Gel of Aceclofenac and it's In-vitro Characterization " Asian Journal of Drugs,2017, 5/(2) 78-87.

6.   AartiHardia, DarshanJamindar, Amisha Mahajan, AashishHardia“ Formuation and In vitro and skin permeability evaluation of Dexamethasone loaded Niosomal gel” ,Asian journal of pharmaceutical research and development, Vol5(2)March-April.2017:1-09.

7.   Moghassemi S, Hadjizadeh A (July 2014). "Nano-niosomes as nanoscale drug delivery systems: an illustrated review". Journal of Controlled Release. 185: 22–36. doi:10.1016/j.jconrel.2014.04.015. PMID 24747765.

8.   Buckton G., Harwood, Interfacial phenomena in Drug Delivery and Targeting Academic Publishers, Switzerland. 1995; p.154-155.

9.   Khan A, Sharma PK, Visht S, Malviya R. Niosomes as colloidal drug delivery system: a review. Journal of Chronotherapy and Drug Delivery. 2011;2:15–21.

10.    Gayatri Devi S, Venkatesh P, Udupa N. Niosomal sumatriptan succinate for nasal administration. Int J Pharm Sci 2000;62:479-81.

11.    Baillie A.J., Coombs G.H. and Dolan T.F. Non-ionic surfactant vesicles, niosomes, as delivery system for the anti-leishmanial drug, sodium stribogluconate  J.Pharm.Pharmacol. 1986; 38: 502-505.

12.    Raja Naresh R.A., Chandrashekhar G., Pillai G.K. and Udupa N. Antiinflammatory activity of Niosome encapsulated diclofenac sodium with Tween -85 in Arthitic rats. Ind.J.Pharmacol. 1994; 26:46-48.

13.    Maver L.D. Bally M.B. Hope. M.J. Cullis P.R. Biochem Biophys. Acta (1985), 816:294-302.

14.    Chauhan S. and Luorence M.J. The preparation of polyoxyethylene containing non-ionic surfactant. vesicles. J. Pharm. Pharmacol. 1989; 41: 6p.

15.    Blazek-Walsh A.I. and Rhodes D.G. Pharm. Res. SEM imaging predicts quality of niosomes from maltodextrin-based proniosomes. 2001; 18: 656-661.

16.    Baillie AJ, Coombs GH, Dolan TF, Laurie J. Non-ionic surfactant vesicles, niosomes, as delivery system for the anti-leishmanial drug, sodium stibogluconate. J Pharm Pharmacol. 1986;38:502–5.

17.    Khandare JN, Madhavi G, Tamhankar BM. Niosomes novel drug delivery system. East Pharmacist. 1994;37:61–4.

18.    Jayaraman SC, Ramachandran C, Weiner N. Topical delivery of erythromycin from various formulations: An in vivo hairless mouse study. J Pharm Sci. 1996;85:1082–4.

19.    Pardakhty A, Varshosaz J, Rouholamini A. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm. 2007;328:130–41.

20.     Y, Zhao F, Li N, Yang Y, Li K. Studies on a high encapsulation of colchicines by a noisome system. Int J Pharm. 2002;244:73–80.

21.    Uchegbu IF, Vyas SP. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm. 1998;172:33–70.

22.    S. Moghassemi and A. Hadjizadeh, “Nano-niosomes as nanoscale drug delivery systems: an illustrated review,” Journal of Controlled Release, vol. 185, no. 1, pp. 22–36, 2014.

23.    Moghassemi S, Hadjizadeh A (July 2014). "Nano-niosomes as nanoscale drug delivery systems: an illustrated review". Journal of Controlled Release. 185: 22–36.

24.    Puras G, Mashal M, Zárate J, Agirre M, Ojeda E, Grijalvo S, Eritja R, Diaz-Tahoces A, Martínez Navarrete G, Avilés-Trigueros M, Fernández E, Pedraz JL (January 2014). "A novel cationic niosome formulation for gene delivery to the retina". Journal of Controlled Release. 174: 27–36.

25.    Aggarwal G, Goel A, Dhawan S, Shama A (2010). "Carriers/vesicles based approaches for penetration enhancement in transdermal drug delivery (1 - 5).

 

Related Images:



Recent Images



Assessing Philippine Health Care Coverage Gaps: An Assessment of Accessibility of Public Health Programs in Selected Barangay in Imus, Cavite, Philippines
Isoabsorptive UV Spectrophotometry Method development and validation for simultaneous estimation of Eslicarbazepine Acetate and Carbamazepine
To develop and validate the stability indicating method for repaglinide and voglibose using HPLC method
To develop and validate the stability indicating method for Empagliflozin and Linagliptin using HPLC method
A Prospective Observational Study on the Clinical Evaluation of Vertigoin Young Adult Population of Amaravati Capital Region
Quality by Design-Based Analytical Method Development and Validation of Suzetrigine by RP - HPLC
Formulation, Optimization and Evaluation of Rimegepant Pulsatile Tablets for Chronotherapeutic Management of Migraine
Development and Evaluation of Ticagrelor Solid Dispersion Tablets Using PVP K30, PEG 6000 and HPMC E5 for Dissolution Enhancement
To study the effect of various superdisintegrants and binders in the Formulation and Evaluation of Labetalol Rapid Disintegrating Tablet
To Develop and Validate the Stability Indicating Method for Ezetimibe and Rosuvastatin Using HPLC Method

Tags


Quick Links


Latest Issues

Popular Articles